Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS - Get Free Report) saw a large decrease in short interest in April. As of April 15th, there was short interest totaling 1,057,887 shares, a decrease of 59.2% from the March 31st total of 2,590,322 shares. Based on an average daily volume of 321,797 shares, the short-interest ratio is currently 3.3 days. Approximately 3.4% of the company's shares are short sold.
Institutional Investors Weigh In On Neuberger Berman High Yield Strategies Fund
Several institutional investors have recently added to or reduced their stakes in NHS. GraniteShares Advisors LLC purchased a new stake in Neuberger Berman High Yield Strategies Fund during the 4th quarter valued at $2,832,000. Guggenheim Capital LLC boosted its position in Neuberger Berman High Yield Strategies Fund by 38.0% during the 4th quarter. Guggenheim Capital LLC now owns 567,943 shares of the investment management company's stock valued at $4,225,000 after buying an additional 156,386 shares during the period. Shaker Financial Services LLC purchased a new stake in Neuberger Berman High Yield Strategies Fund during the 4th quarter valued at $402,000. Total Wealth Planning & Management Inc. purchased a new stake in Neuberger Berman High Yield Strategies Fund during the 4th quarter valued at $337,000. Finally, Balyasny Asset Management L.P. purchased a new stake in Neuberger Berman High Yield Strategies Fund during the 2nd quarter valued at $338,000.
Neuberger Berman High Yield Strategies Fund Price Performance
Shares of Neuberger Berman High Yield Strategies Fund stock traded down $0.05 during trading on Friday, reaching $6.35. The company's stock had a trading volume of 168,589 shares, compared to its average volume of 266,930. Neuberger Berman High Yield Strategies Fund has a 52-week low of $6.26 and a 52-week high of $7.80. The firm's 50-day moving average is $6.95 and its two-hundred day moving average is $7.22.
Neuberger Berman High Yield Strategies Fund Dividend Announcement
The company also recently declared a monthly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, April 7th will be given a dividend of $0.0905 per share. The ex-dividend date of this dividend is Tuesday, April 7th. This represents a c) annualized dividend and a yield of 17.1%.
About Neuberger Berman High Yield Strategies Fund
(
Get Free Report)
The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.
Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Neuberger Berman High Yield Strategies Fund, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neuberger Berman High Yield Strategies Fund wasn't on the list.
While Neuberger Berman High Yield Strategies Fund currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.